切口负压伤口治疗与标准敷料对严重创伤下肢骨折术后深部手术部位感染的影响:WHIST随机临床试验
WHIST随机临床试验纳入1548例因严重创伤接受下肢骨折手术的患者,比较切口负压伤口治疗与标准敷料对深部手术部位感染的影响。研究不支持在此类患者中常规使用切口负压伤口治疗。
要点
- 切口负压伤口治疗未显著降低严重创伤下肢骨折术后30天深部手术部位感染率。
- 5项预设次要结局在各时间点均无显著差异,不支持常规使用该疗法。
核心结论
- 在严重创伤相关下肢骨折手术患者中,切口负压伤口治疗与标准敷料相比,深部手术部位感染率无显著差异。
- 研究结果不支持在该人群中常规使用切口负压伤口治疗。
研究设计与样本
- 随机临床试验,在英国24家主要创伤网络医院开展。
- 纳入1548例16岁及以上因严重创伤接受下肢骨折手术的患者,随机分为切口负压伤口治疗组(n=785)和标准敷料组(n=763)。
- 主要结局为30天深部手术部位感染,依据美国CDC标准诊断;预设次要分析为90天主要结局。
主要发现
- 5项预设次要结局(患者报告残疾、健康相关生活质量、手术瘢痕评估、慢性疼痛及其他局部伤口愈合并发症)在各时间点均无显著差异。
关键数值与推荐
- 主要结局诊断依据美国CDC手术部位感染标准。
临床怎么用
- 对于严重创伤相关下肢骨折术后切口,不应常规使用切口负压伤口治疗以降低深部手术部位感染。
- 临床决策应结合个体情况,但本试验未显示该疗法优于标准敷料。
局限性
- 30天事件率低于预期,可能影响统计效能。
- 随访至90天,长期结局未报告。
- 结果外推需谨慎,仅适用于严重创伤相关下肢骨折手术人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Following surgery to treat major trauma-related fractures, deep wound infection rates are high. It is not known if negative pressure wound therapy can reduce infection rates in this setting. OBJECTIVE: To assess outcomes in patients who have incisions resulting from surgery for lower limb fractures related to major trauma and were treated with either incisional negative pressure wound therapy or standard wound dressing. DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial conducted at 24 trauma hospitals representing the UK Major Trauma Network that included 1548 patients aged 16 years or older who underwent surgery for a lower limb fracture caused by major trauma from July 7, 2016, through April 17, 2018, with follow-up to December 11, 2018. INTERVENTIONS: Incisional negative pressure wound therapy (n = 785), which involved a specialized dressing used to create negative pressure over the wound, vs standard wound dressing not involving negative pressure (n = 763). MAIN OUTCOMES AND MEASURES: The primary outcome measure was deep surgical site infection at 30 days diagnosed according to the criteria from the US Centers for Disease Control and Prevention. A preplanned secondary analysis of the primary outcome was performed at 90 days. The secondary outcomes were patient-reported disability (Disability Rating Index), health-related quality of life (EuroQol 5-level EQ-5D), surgical scar assessment (Patient and Observer Scar Assessment Scale), and chronic pain (Douleur Neuropathique Questionnaire) at 3 and 6 months, as well as other local wound healing complications at 30 days. RESULTS: Among 1548 participants who were randomized (mean [SD] age, 49.8 [20.3] years; 561 [36%] were aged ≤40 years; 583 [38%] women; and 881 [57%] had multiple injuries), 1519 (98%) had data available for the primary outcome. At 30 days, deep surgical site infection occurred in 5.84% (45 of 770 patients) of the incisional negative pressure wound therapy group and in 6.68% (50 of 749 patients) of the standard wound dressing group (odds ratio, 0.87 [95% CI, 0.57 to 1.33]; absolute risk difference, -0.77% [95% CI, -3.19% to 1.66%]; P = .52). There was no significant difference in the deep surgical site infection rate at 90 days (11.4% [72 of 629 patients] in the incisional negative pressure wound therapy group vs 13.2% [78 of 590 patients] in the standard wound dressing group; odds ratio, 0.84 [95% CI, 0.59 to 1.19]; absolute risk difference, -1.76% [95% CI, -5.41% to 1.90%]; P = .32). For the 5 prespecified secondary outcomes reported, there were no significant differences at any time point. CONCLUSIONS AND RELEVANCE: Among patients who underwent surgery for major trauma-related lower limb fractures, use of incisional negative pressure wound therapy, compared with standard wound dressing, resulted in no significant difference in the rate of deep surgical site infection. The findings do not support the use of incisional negative pressure wound therapy in this setting, although the event rate at 30 days was lower than expected. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN12702354.
引用
- Costa ML, Achten J, Knight R, et al. Effect of Incisional Negative Pressure Wound Therapy vs Standard Wound Dressing on Deep Surgical Site Infection After Surgery for Lower Limb Fractures Associated With Major Trauma: The WHIST Randomized Clinical Trial. JAMA. 2020. PMID: 32044942. doi:10.1001/jama.2020.0059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。